As medtech companies eye entry into the IVL space, Shockwave Medical is consolidating its position through innovation and ...

Shockwave Medical, Inc. SWAV recently announced the full U.S. commercial availability of the Shockwave L6 Peripheral Intravascular Lithotripsy (IVL) Catheter. This follows the receipt of the FDA’s ...

Next-generation intravascular lithotripsy (IVL) catheter resets physicians' expectations by addressing unmet needs in deliverability, lesion crossing and balloon repositioning Shockwave C2 Aero ...

Physicians have a number of tools to treat coronary artery disease, the most common type of heart disease in the United States. But one breakthrough technology being offered at Catholic Medical Center ...

Johnson & Johnson has officially launched its Shockwave C2 Aero Coronary IVL Catheter globally. Enhanced deliverability and repositioning capabilities target calcified coronary artery disease The ...

Patients suffering from peripheral artery disease (PAD) are increasingly being offered a treatment by doctors called intravascular lithotripsy (IVL). Developed by Shockwave Medical, part of Johnson & ...

Shockwave Medical Inc., which is focused on intravascular lithotripsy (IVL) to treat severely calcified cardiovascular disease, saw its stock value rise Friday (NASDAQ:SWAV), eventually closing at $78 ...

SANTA CLARA, Calif., Oct. 19, 2023 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (SWAV), a pioneer in the development and commercialization of transformational technologies for the treatment of ...